Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes
however, this reflects the early stage of research in this field
Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM
PlexusDx supports this precision-wellness approach by integrating renal biomarker context with genetic predisposition data to help providers make informed, individualized treatment decisions
Even at lower doses (4 mg and 8 mg), statistically significant and clinically meaningful weight reductions were observed compared to placebo
Therefore, we focus on the biological characteristics of GLP-1, render an overview of the mechanism of GLP-1 effects in diseases, and investigate the potential of GLP-1 analogues for the treatment of related diseases in this review